An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015
Conclusions: These results, along with the safety data from the prelicensure clinical trials, confirm that the HPV4 vaccine has a favorable safety profile. Key policy, medical and regulatory organizations around the world have independently reviewed these data and continue to recommend routine HPV vaccination.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Vaccine Reports Source Type: research
More News: Anal Cancer | Anaphylactic Shock | Autoimmune Disease | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Clinical Trials | Gardasil | Genital Warts | Health | Human Papillomavirus (HPV) | Infectious Diseases | International Medicine & Public Health | Lupus | Multiple Sclerosis | Pediatrics | Pregnancy | Skin | Stroke | Study | Thrombosis | Vaccines | Warts | Women